Teleradiology

 

DACH operators should feel positive about 2021

Despite one of the panellists at HBI's DACH-State of the Regions broadcast last week labelling 2020 "the wildest year in recent history in the healthcare sector", there are lots of reasons to feel positive about Europe's German-speaking countries as we look towards the new year.

Operators in Russia and ex-CIS hit hard by COVID

State financing has seen little growth in expenditure in Russia over the last couple of years, while former CIS countries are struggling to fund robust healthcare systems. Despite this, panellists at HBI's Russia and Former CIS - State of the Regions discussion last week found some reasons to be positive.

Medica buys Irish diagnostics/teleradiology group for 8-10x EBITDA

The UK's largest teleradiology provider Medica has acquired Global Diagnostics Ireland (GDI), which does eye screening, diagnostic managed services and teleradiology. With only a minority of revenue from the latter, we ask CEO Stuart Quin what this expansion outside of Medica's core business means for its strategy.

Interview: Stuart Quin, CEO, Medica Group

What is the outlook for the UK teleradiology sector, with the largest player Medica's elective volumes still less than half of pre-COVID levels? We talk to CEO Stuart Quin about the group's recent H1 results and its strategy around specialist reporting, AI solutions, diversification and internationalisation, the latter of which has shifted since we last spoke.

Interview: Nasser Al Hagbani, CEO, Dr. Sulaiman Al Habib Medical Services Group

Saudi/UAE hospital operator Dr. Sulaiman Al Habib Medical Services Group (HmG) is by far the largest player by revenue in the GCC at $1.3bn. Shares have all but doubled since its IPO in March, making it the sixth-largest hospital stock globally by market capitalisation at $8.5bn. Its lucrative tele-ICU centre is the largest in the world by beds monitored. In this exclusive interview, Hagbani discusses HmG's listing, business model, Saudisation efforts, declining expat market and of course COVID-19.

Adding value post-COVID – where are the easy wins?

How do you add value to a business in a post COVID world - and are there any easy wins for new acquisitions? On Wednesday last week, an online audience heard HBI365's lively Q&A panel with with Ameos CEO Dr Axel Paeger, McKinsey partner Sebastian Sieler, and L Catterton managing partner Chinta Bhagat.

Health care values look high

Analyst forecasts suggest that healthcare sector valuations have been largely unaffected by the crisis, with EMEA hospitals and medtech stocks now being more expensive than before the Covid outbreak, both on an EBITDA and PE multiples basis.

Unilabs’ TMC muscling in on UK teleradiology market

Unilabs' teleradiology arm European Telemedicine Clinic (TMC) has launched a specialised oncology offering in the UK where it now has a 20% market share, its country head tells HBI. He adds that COVID-19 has seen NHS radiology departments clear routine imaging reporting lists for the first time in 20 years, although outsourcing is picking up again.

Teleradiology’s elective volumes crash

Teleradiology providers across Europe have seen volumes crash for elective reads because of the shut down of non-essential work in public hospitals, while emergency reads have been less badly affected. But operators' low fixed costs should mean that profits will hold.

Find Us